EUROFINS SCIENT Cash Flow from Financial Activities 2018-2023 | ERFSF
EUROFINS SCIENT annual/quarterly cash flow from financial activities history and growth rate from 2018 to 2023. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- EUROFINS SCIENT cash flow from financial activities for the quarter ending June 30, 2023 was $-0.328B, a 452.09% decline year-over-year.
- EUROFINS SCIENT cash flow from financial activities for the twelve months ending June 30, 2023 was $-2.326B, a 956.12% decline year-over-year.
- EUROFINS SCIENT annual cash flow from financial activities for 2022 was $-0.328B, a 69.55% decline from 2021.
- EUROFINS SCIENT annual cash flow from financial activities for 2021 was $-1.077B, a 1839.94% increase from 2020.
- EUROFINS SCIENT annual cash flow from financial activities for 2020 was $-0.056B, a 85.51% decline from 2019.
| EUROFINS SCIENT Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2022 | $-328 |
| 2021 | $-1,077 |
| 2020 | $-56 |
| 2019 | $-383 |
| 2018 | $816 |
| 2017 | $1,518 |
| 2016 | $ |
| 2015 | $ |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.394B | $7.051B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.556B | 15.38 |
| Cencora (COR) | United States | $47.310B | 18.44 |
| ICON (ICLR) | Ireland | $26.285B | 24.82 |
| DiDi Global (DIDIY) | China | $21.823B | 0.00 |
| Avantor (AVTR) | United States | $14.665B | 21.59 |
| CochLear (CHEOY) | Australia | $14.459B | 0.00 |
| Natera (NTRA) | United States | $13.261B | 0.00 |
| Revvity (RVTY) | United States | $13.239B | 23.22 |
| Medpace Holdings (MEDP) | United States | $12.486B | 41.08 |
| Viatris (VTRS) | United States | $11.966B | 3.58 |
| Charles River Laboratories (CRL) | United States | $10.807B | 20.69 |
| Solventum (SOLV) | United States | $9.209B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.426B | 0.00 |
| HealthEquity (HQY) | United States | $7.373B | 47.34 |
| Organon (OGN) | United States | $5.233B | 4.96 |
| Bausch + Lomb (BLCO) | Canada | $5.186B | 20.76 |
| Doximity (DOCS) | United States | $5.110B | 35.79 |
| PACS (PACS) | United States | $4.461B | 0.00 |
| Life Times (LTH) | United States | $3.655B | 38.29 |
| Sotera Health (SHC) | United States | $3.210B | 15.75 |
| Surgery Partners (SGRY) | United States | $3.184B | 29.13 |
| GoodRx Holdings (GDRX) | United States | $3.062B | 116.57 |
| Agilon Health (AGL) | United States | $2.772B | 0.00 |
| Progyny (PGNY) | United States | $2.450B | 42.18 |
| NovoCure (NVCR) | Jersey | $2.092B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.996B | 7.91 |
| Premier (PINC) | United States | $1.906B | 8.15 |
| BrightSpring Health Services (BTSG) | United States | $1.802B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.711B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.444B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.197B | 0.00 | |
| CareDx (CDNA) | United States | $0.733B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.721B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| Pediatrix Medical (MD) | United States | $0.649B | 6.88 |
| Auna S.A (AUNA) | Luxembourg | $0.592B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| InnovAge Holding (INNV) | United States | $0.575B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.435B | 43.40 |
| ModivCare (MODV) | United States | $0.381B | 7.12 |
| Sonida Senior Living (SNDA) | United States | $0.379B | 0.00 |
| LifeMD (LFMD) | United States | $0.327B | 0.00 |
| DocGo (DCGO) | United States | $0.318B | 17.39 |
| Sharecare (SHCR) | United States | $0.290B | 0.00 |
| MultiPlan (MPLN) | United States | $0.246B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.237B | 0.00 |
| Beauty Health (SKIN) | United States | $0.223B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| So-Young (SY) | China | $0.107B | 51.51 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.88 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| Oncology Institute (TOI) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.001B | 0.00 |